Cancer-Linked Contaminant Found in Heartburn Medication: FDA

A pharmacy technician grabs a bottle of drugs off a shelve at the central pharmacy of Intermountain Heathcare in Midvale, Utah on Sept. 10, 2018. George Frey/Getty Images

Low levels of a carcinogenic substance were discovered in heartburn medication Zantac and its generic variants, according to the U.S. Food and Drug Administration (FDA) in a statement on Sept. 14.

The chemical NDMA, or N-Nitrosodimethylamine, has been linked to an increased risk in several different kinds of cancers.